|
SEMINAR 1
|
|
Chairs: A Attanasio (Agliano Terme, Italy),
|
|
EM Erfurth (Lund, Sweden)
|
| |
|
Is growth hormone replacement therapy in adults cost-effective?
|
|
NICE growth hormone - lessons from the UK
|
|
PM Stewart (Birmingham, UK)
|
|
The burden of neuroendocrine diseases in a low budget health-care
system
|
|
J Marek (Praha, Hungary)
|
|
A debate about the effects of growth hormone replacement
on quality of life
|
|
A Barkan (Ann Arbor, MI, USA) and S Shalet
(Manchester, UK)
|
|
|
|
SEMINAR 2
|
|
Chairs: K Post (New York, NY, USA),
|
| A Beckers (Liege, Belgium) |
| |
|
The face of old problems
|
|
The re-emergence of Sheehan's syndrome in Western Europe
|
|
F Kelestimur (Kayseri, Turkey)
|
|
Traumatic brain injury: endocrine effects
|
|
G Aimaretti (Turin, Italy)
|
| Primary pituitary lymphoma: An emerging clinical
entity |
| A Giustina ( Brescia, Italy) |
| |
|
SEMINAR 3
|
|
Chairs: H Turner (Oxford, UK),
|
|
V Bonert (Los Angeles, CA, USA)
|
| |
|
New aspects of prolactin in health and disease
|
|
Is a medical cure of prolactinomas possible?
|
|
A Colao (Naples, Italy)
|
|
Psychological stress and hyperprolactinemia
|
|
L Sobrinho (Lisbon, Portugal)
|
|
Dopamine resistance of prolactinomas
|
|
M Molitch (Chicago, IL, USA)
|
| |
|
SEMINAR 4
|
|
Chairs: J Schlechte (Iowa City, IA, USA),
|
|
Y Greenman (Tel Aviv, Israel)
|
| |
|
Do the results of the women's health initiative have impact
on hormone replacement therapy for hypopituitarism?
|
|
Introduction to the theme
|
|
C Wang (Torrance, CA, USA)
|
|
Estrogen replacement therapy
|
|
S Berga (Pittsburgh, PA, USA)
|
|
Androgen deficiency in women with hypopituitarism
|
|
K Miller (Boston, MA, USA)
|
| |
|
SEMINAR 5
|
|
Chairs: A Schonbrunn (Houston, TX, USA),
|
|
N Horseman (Cincinnati, OH, USA)
|
| |
|
New technologies
|
|
Mechanism of pituitary cell secretion (studies using atomic
force microscopy)
|
|
B Jena (Detroit, MI, USA)
|
|
The use of BRET for detecting protein interactions in cellular
functions
|
|
K Eidne (Perth, Australia)
|
|
The use of imaging (MRI and PET) for small (transgenic or
knockout) animals
|
|
N Beckmann (Basel, Switzerland)
|
| |
|
SEMINAR 6
|
|
Chairs: L Frohman (Chicago, IL, USA),
|
|
P Chanson (Kremlin-Bicetre, France)
|
| |
|
Polymorphisms in pituitary hormone genes: the impact in
the normal population
|
|
Glucocorticoid receptor gene
|
|
E van Rossum (Rotterdam, The Netherlands)
|
|
Growth hormone receptor
|
|
K Chihara
|
|
LH/FSH and their receptors
|
|
I Huhtaniemi (London, UK)
|
| |
|
SEMINAR 7
|
|
Chairs: S Ezzat (Toronto, Canada),
|
|
R Salvatore (Baltimore, MD, USA)
|
| |
|
The pituitary in the frail elderly
|
|
GH-IGF axis in frail elderly
|
|
A Hoffman (Palo Alto, CA, USA)
|
|
Testosterone
|
|
S Bhasin (Los Angeles, CA, USA)
|
|
DHEA
|
|
W Arlt
|
| |
|
SEMINAR 8
|
|
Chairs: M Tschopf (Potsdam-Rehbrücke, Germany),
|
|
C Auernhammer (Munich, Germany)
|
| |
|
New aspects of growth hormone and PRL actions
|
|
Overview of growth hormone and IGF actions in the central
nervous system
|
|
T Wood (Hershey, PA, USA)
|
|
Mechanisms for storing pituitary hormones: implications for
controlling hormone release
|
|
PS Dannies (New Haven, CT, USA)
|
|
GH effects on fat metabolism and obesity
|
|
D Flint
|